Cargando…
The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507553/ https://www.ncbi.nlm.nih.gov/pubmed/23173143 http://dx.doi.org/10.2337/dc12-0954 |
| _version_ | 1782251079296090112 |
|---|---|
| author | Vaccaro, Olga Masulli, Maria Bonora, Enzo Del Prato, Stefano Nicolucci, Antonio Rivellese, Angela A. Riccardi, Gabriele |
| author_facet | Vaccaro, Olga Masulli, Maria Bonora, Enzo Del Prato, Stefano Nicolucci, Antonio Rivellese, Angela A. Riccardi, Gabriele |
| author_sort | Vaccaro, Olga |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3507553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35075532013-12-01 The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes Vaccaro, Olga Masulli, Maria Bonora, Enzo Del Prato, Stefano Nicolucci, Antonio Rivellese, Angela A. Riccardi, Gabriele Diabetes Care Online Letters: Observations American Diabetes Association 2012-12 2012-11-14 /pmc/articles/PMC3507553/ /pubmed/23173143 http://dx.doi.org/10.2337/dc12-0954 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Observations Vaccaro, Olga Masulli, Maria Bonora, Enzo Del Prato, Stefano Nicolucci, Antonio Rivellese, Angela A. Riccardi, Gabriele The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title | The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title_full | The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title_fullStr | The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title_full_unstemmed | The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title_short | The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes |
| title_sort | tosca.it trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes |
| topic | Online Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507553/ https://www.ncbi.nlm.nih.gov/pubmed/23173143 http://dx.doi.org/10.2337/dc12-0954 |
| work_keys_str_mv | AT vaccaroolga thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT masullimaria thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT bonoraenzo thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT delpratostefano thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT nicolucciantonio thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT rivelleseangelaa thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT riccardigabriele thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT thetoscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT vaccaroolga toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT masullimaria toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT bonoraenzo toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT delpratostefano toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT nicolucciantonio toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT rivelleseangelaa toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT riccardigabriele toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes AT toscaittrialastudydesignedtoevaluatetheeffectofpioglitazoneversussulfonylureasoncardiovasculardiseaseintype2diabetes |